Roche Diagnostics Growing at 50% Rate in China

Roche Diagnostics has been experiencing annual revenue increases of close to 50% per year, and the company expects the large increases to continue, driven by the PRC’s investment into healthcare. Roche Diagnostics thinks China will soon become its fifth largest market, up from eighth last year. Roche Diagnostics is the biggest seller of in vitro diagnostic tests in China. A full 80% of Roche’s IVD products are available in China, and Roche is working on registering many of the remaining products. More details... Stock Symbol: (VX: ROG)